As our findings showed that the administration of CANA decreases the skeletal muscle mass during the pair-feeding, but not during the ad libitum feeding, further studies will be needed to ask whether SGLT2 inhibitors can affect the skeletal muscle mass in various conditions, including diabetes or HFD-fed state under food restriction. The gene discussed is SLC5A2; the disease is diabetes mellitus.